Timber Hill’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Timber Hill’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,796	Closed	-$338K	–	2495
2015 Q2	$338K	Buy	+5,796	New	+$339K	﹤0.01%	2094
2015 Q1	–	Sell	-6,252	Closed	-$316K	–	2485
2014 Q4	$316K	Buy	+6,252	New	+$305K	﹤0.01%	2136
2014 Q2	–	Sell	-4,737	Closed	-$200K	–	2838
2014 Q1	$200K	Sell	4,737 -1,125	-19%	-$47.2K	﹤0.01%	2582
2013 Q4	$231K	Buy	+5,862	New	+$220K	﹤0.01%	2752

Other funds holding IHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BWM

Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Timber Hill's IHE Position: Q3 2015 in Review

Timber Hill sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2015, closing a stake of 5,796 shares — an estimated $338K sold.

Timber Hill first reported a position in IHE in Q4 2013 and held it in 4 quarters. The position peaked at $338K in Q2 2015. 102 funds tracked by Wall St. Rank hold IHE as of Q3 2015.

Timber Hill reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Timber Hill sold 5,796 iShares US Pharmaceuticals ETF shares in Q3 2015, an estimated $338K.
Timber Hill first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 4 quarters.
Timber Hill's iShares US Pharmaceuticals ETF position peaked at $338K in Q2 2015.
102 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2015.

Based on Timber Hill's 13F filing for Q3 2015, filed 2 Nov 2015.